Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Androgenetic Alopecia Treatment Market Forecast: What Value Will The Market Reach By 2030?
The androgenetic alopecia treatment market has demonstrated robust expansion in recent years. Its valuation is projected to rise from $2.44 billion in 2025 to $2.62 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.2%. The growth observed in the past can be attributed to rising awareness about hair loss solutions, the growing prevalence of androgenetic alopecia, increasing use of finasteride and minoxidil, the expansion of dermatology clinics, and the adoption of traditional hair transplant procedures.
The androgenetic alopecia treatment market is poised for significant expansion over the coming years. This market is projected to reach a valuation of $3.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This anticipated growth during the forecast period is attributable to several factors, including advancements in laser and device therapies, the emergence of personalized and precision medicine approaches, the integration of AI in diagnosing hair loss, the expansion of teledermatology platforms, and an increasing demand for minimally invasive hair restoration procedures. Key trends anticipated during this period encompass personalized hair loss treatments, minimally invasive hair restoration methods, natural and herbal solutions for hair growth, the use of teledermatology and remote hair care consultations, and various combination therapy approaches.
Get A Free Sample Report With In-Depth Market Insights:
Androgenetic Alopecia Treatment Market Industry Drivers: What’s Behind The Revenue Growth?
An increase in hair loss incidents is anticipated to drive the expansion of the androgenetic alopecia treatment market in the future. Hair loss, also known as alopecia, denotes the shedding of hair, either partially or entirely, from the scalp or other bodily regions. Instances of hair loss are linked to factors such as inadequate nutrition, shifts in hormones, genetic predisposition, and elevated stress levels. Treatments for androgenetic alopecia operate via diverse approaches, such as balancing hormones, encouraging follicle activity, and performing surgical repair, all aimed at controlling hair loss and fostering new hair growth. To illustrate, in 2024, the National Health Service, a government body based in the UK, reported that approximately 8 million women and 6.5 million men in the UK suffer from hair loss. Furthermore, over 650,000 hair transplants are performed annually. Consequently, the growing number of hair loss occurrences fuels the androgenetic alopecia treatment market.
Androgenetic Alopecia Treatment Market Segments: Where Is Growth Concentrated?
The androgenetic alopecia treatment market covered in this report is segmented –
1) By Treatment Type: Pharmaceutical, Device
2) By Medication Type: Prescription, Over-The-Counter
3) By Gender: Male, Female
4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users
Subsegments:
1) By Pharmaceutical: Oral Medications ( Finasteride), Topical Medications (Minoxidil), Hormonal Therapy
2) By Device: Laser Therapy Devices, Hair Transplant Devices, Scalp Micropigmentation Devices
#Androgenetic Alopecia Treatment Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the androgenetic alopecia treatment market are actively developing innovative pharmaceutical options to address hair loss. These advancements involve diverse mechanisms such as stimulating hair follicle regeneration, blocking hormones responsible for hair loss, and employing advanced delivery systems including topical applications and oral drugs. As an illustration, in June 2023, Pfizer Inc., a US-based healthcare company, announced that the FDA had approved LITFULO (ritlecitinib). This is an oral, once-daily treatment for individuals 12 years of age and older who have severe alopecia areata. LITFULO functions as a kinase inhibitor, specifically targeting Janus kinase 3 (JAK3) and the tyrosine kinase expressed in the hepatocellular carcinoma (TEC) family of kinases. The FDA approval was granted based on findings from the ALLEGRO Phase 2b/3 trial, which indicated that 23% of patients treated with LITFULO 50mg achieved 80% or more scalp hair coverage after six months, compared to 1.6% in the placebo group. This solution offers a new therapeutic choice for individuals experiencing significant hair loss, thereby addressing a previously unmet need in the treatment of alopecia areata.
Androgenetic Alopecia Treatment Market Key Participants And Competitive Landscape
Major companies operating in the androgenetic alopecia treatment market are Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Fagron Inc., Curallux LLC, Theradome Inc., Lexington International, Apira Science Inc., Freedom Laser Therapy Inc., Follica Inc., Histogen Inc., Aclaris Therapeutics Inc., HCell Inc., Cosmo Pharmaceuticals N.V., AbbVie Inc., Daiichi Sankyo Company Limited
View The Full Androgenetic Alopecia Treatment Market Report:
Androgenetic Alopecia Treatment Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the androgenetic alopecia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
